William Chase on Abbott's M&A strategy - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

William Chase on Abbott's M&A strategy

Published November 19, 2012 at 1:04 PM


William Chase, Abbott Laboratories' vice president of licensing and acquisitions, and The Deal Pipeline's Ben Fidler discuss the pharmaceutical giant's acquisition strategy as it prepares to split into two different companies at the start of 2013. - George White

Share:

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

Geoffrey F. Aronow joined Sidley Austin LLP as a partner in the global securities and derivatives enforcement and regulatory practice. For other updates launch today's Movers & shakers slideshow.

Video

Procter & Gamble set to throw out the Duracell

The battery business has always been a peckish one, prone to flare ups of price wars. And selling disposable D-cells isn't as remunerative as it once was. More video

Sectors